🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will look at your body's response to the new immunizations. We w...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2007-07-10
Trial ID
NCT00505063
A single center, open labeled phase I/IIa study to evaluate safety, tolerab...
Status
Completed
Location
Bundang CHA General Hospital
Start Date
2014-10-28
Trial ID
NCT02693652
Treatments Being Tested
In this study the safety and immunogenicity of 2 different formulations of ...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1998-03
Trial ID
NCT00697775
Treatments Being Tested
Infants of hepatitis B virus (HBV)-infected mothers with positive hepatitis...
Status
Completed
Location
Nanjing Drum Tower Hospital
Start Date
2012-04
Trial ID
NCT01637844
Treatments Being Tested
The purpose of the present study is to evaluate the immunogenicity and safe...
Status
Completed
Location
Multiple Locations
Start Date
2000-08
Trial ID
NCT00697866
Treatments Being Tested
The focus of this study is to evaluate how risk factors like age, gender, b...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-11-24
Trial ID
NCT00289731
Treatments Being Tested
The purpose of this study is to compare the effects of (a) immunization set...
Status
Completed
Location
University of California San Francisco Medical Cen
Start Date
2004-08
Trial ID
NCT00244374
Treatments Being Tested
This study is conducted to assess safety and immunogenicity of GSK's HBsAg ...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-10-04
Trial ID
NCT05561673
Treatments Being Tested
This study evaluates the safety and immunogenicity of the candidate HBV-MPL...
Status
Completed
Location
GSK Clinical Trials Call Center
Start Date
1997-03
Trial ID
NCT00697216
Treatments Being Tested
To evaluate the persistence of anti-hepatitis A virus (anti-HAV) and anti-h...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-05
Trial ID
NCT00197119
Treatments Being Tested